Home › Asset managers › Franklin Templeton › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Franklin Templeton voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
5,401 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Franklin Templeton voted | Funds |
|---|---|---|---|---|---|---|---|
| Bharat Electronics Limited | August 28, 2025 | Elect Harikumar Raghavan Nair as Director | Director Elections | Board | AGAINST | 2 | |
| Bharat Electronics Limited | August 28, 2025 | Elect Kamesh Kasana as Director | Director Elections | Board | AGAINST | 2 | |
| Bharat Electronics Limited | August 28, 2025 | Elect Meera Mohanty as Director | Director Elections | Board | AGAINST | 2 | |
| Bharat Electronics Limited | August 28, 2025 | Elect Rajnish Sharma as Director | Director Elections | Board | AGAINST | 2 | |
| Bharat Electronics Limited | August 28, 2025 | Reelect K V Suresh Kumar as Director | Director Elections | Board | AGAINST | 2 | |
| Bharat Heavy Electricals Limited | August 19, 2025 | Elect Aashish Chaturvedi as Director | Director Elections | Board | AGAINST | 2 | |
| Bharat Heavy Electricals Limited | August 19, 2025 | Elect Ashok Kumar Aseri as Director | Director Elections | Board | AGAINST | 2 | |
| Bharat Heavy Electricals Limited | August 19, 2025 | Elect Serugulathur Mahadevan Ramanathan as Director | Director Elections | Board | AGAINST | 2 | |
| Bharat Heavy Electricals Limited | August 19, 2025 | Reelect Bani Varma as Director | Director Elections | Board | AGAINST | 2 | |
| Bharat Heavy Electricals Limited | August 19, 2025 | Reelect Tajinder Gupta as Director | Director Elections | Board | AGAINST | 2 | |
| Bilibili, Inc. | June 17, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| Bilibili, Inc. | June 17, 2026 | Approve PricewaterhouseCoopers and PricewaterhouseCoopers Zhong Tian LLP as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 | |
| Bilibili, Inc. | June 17, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| BioCryst Pharmaceuticals, Inc. | June 11, 2026 | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. | Compensation | Board | AGAINST | 2 | |
| BioCryst Pharmaceuticals, Inc. | June 11, 2026 | To hold a non-binding, advisory vote regarding executive compensation. | Say-on-Pay | Board | AGAINST | 2 | |
| BioNTech SE | May 15, 2026 | Approve Remuneration Report | Compensation | Board | AGAINST | 2 | |
| BioNTech SE | May 15, 2026 | Elect Iris Loew-Friedrich to the Supervisory Board | Director Elections | Board | AGAINST | 2 | |
| Biocon Limited | August 8, 2025 | Approve Increase in the Limits Applicable for Making Investments / Extending Loans and Giving Guarantees or Providing Securities in Connection with Loans to Persons / Bodies Corporate | Capital Structure | Board | AGAINST | 2 | |
| Biocon Limited | December 31, 2025 | Approve Increase in Limits for the Loans and Investment under Section 186 of the Companies Act, 2013 | Capital Structure | Board | AGAINST | 2 | |
| Biocon Limited | June 7, 2026 | Approve Appointment and Remuneration of Shreehas Pradeep Tambe as Chief Executive Officer & Managing Director | Compensation | Board | AGAINST | 2 | |
| Biocon Limited | June 7, 2026 | Approve Revision in Remuneration of Kiran Mazumdar-Shaw as Executive Director Designated as Executive Chairperson | Compensation | Board | AGAINST | 2 | |
| Biocon Limited | June 7, 2026 | Elect Arun Suresh Chandavarkar as Director | Director Elections | Board | AGAINST | 2 | |
| Blue Moon Group Holdings Limited | May 22, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| Blue Moon Group Holdings Limited | May 22, 2026 | Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 | |
| Blue Moon Group Holdings Limited | May 22, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| Bollore SE | May 27, 2026 | Approve Remuneration Policy of Chairman and CEO | Compensation | Board | AGAINST | 2 | |
| Bollore SE | May 27, 2026 | Authorize Repurchase of Up to 9.95 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 2 | |
| Bollore SE | May 27, 2026 | Reelect Bollore Participations SE as Director | Director Elections | Board | AGAINST | 2 | |
| Bollore SE | May 27, 2026 | Reelect Cyrille Bollore as Director | Director Elections | Board | AGAINST | 2 | |
| Bollore SE | May 27, 2026 | Reelect Marie Bollore as Director | Director Elections | Board | AGAINST | 2 | |
| Boston Scientific Corporation | April 30, 2026 | Proposal to elect ten Directors: Cathy R. Smith | Director Elections | Board | AGAINST | 2 | |
| Box, Inc. | June 25, 2026 | Election of Directors: Jack Lazar | Director Elections | Board | AGAINST | 2 | |
| Box, Inc. | June 25, 2026 | Election of Directors: Steve Murphy | Director Elections | Board | AGAINST | 2 | |
| Box, Inc. | June 25, 2026 | Election of Directors: Sue Barsamian | Director Elections | Board | AGAINST | 2 | |
| Box, Inc. | June 25, 2026 | To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 7,200,000 shares. | Compensation | Board | AGAINST | 2 | |
| Brambles Limited | October 23, 2025 | Elect Maxine Nicole Brenner as Director | Director Elections | Board | AGAINST | 2 | |
| Braskem SA | November 13, 2025 | Elect Lucas Cive Barbosa as Director | Director Elections | Board | AGAINST | 2 | |
| Brava Energia SA | April 20, 2026 | Elect Directors | Director Elections | Board | AGAINST | 2 | |
| Brava Energia SA | April 20, 2026 | In Case Cumulative Voting Is Adopted, Do You Wish to Equally Distribute Your Votes Amongst the Nominees below? | Director Elections | Board | ABSTAIN | 2 | |
| Brava Energia SA | April 20, 2026 | Percentage of Votes to Be Assigned - Elect Alexandre Marcelo Marques Cruz as Independent Director | Director Elections | Board | ABSTAIN | 2 | |
| Brava Energia SA | April 20, 2026 | Percentage of Votes to Be Assigned - Elect Andre Marcelo da Silva Prado as Independent Director | Director Elections | Board | ABSTAIN | 2 | |
| Brava Energia SA | April 20, 2026 | Percentage of Votes to Be Assigned - Elect Carlos Alberto Pereira de Oliveira as Independent Director | Director Elections | Board | ABSTAIN | 2 | |
| Brava Energia SA | April 20, 2026 | Percentage of Votes to Be Assigned - Elect Harley Lorentz Scardoelli as Independent Director | Director Elections | Board | ABSTAIN | 2 | |
| Brava Energia SA | April 20, 2026 | Percentage of Votes to Be Assigned - Elect Henrique de Queiroz Galvao as Independent Director | Director Elections | Board | ABSTAIN | 2 | |
| Brava Energia SA | April 20, 2026 | Percentage of Votes to Be Assigned - Elect Mateus Tessler Rocha as Independent Director | Director Elections | Board | ABSTAIN | 2 | |
| Brava Energia SA | April 20, 2026 | Percentage of Votes to Be Assigned - Elect Ricardo de Queiroz Galvao as Independent Director | Director Elections | Board | ABSTAIN | 2 | |
| Brava Energia SA | April 20, 2026 | Percentage of Votes to Be Assigned - Elect Richard Kehrer Kovacs as Director | Director Elections | Board | ABSTAIN | 2 | |
| Brilliance China Automotive Holdings Limited | June 18, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| Brilliance China Automotive Holdings Limited | June 18, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 2 | |
| Brilliance China Automotive Holdings Limited | June 18, 2026 | Elect Jiang Bo as Director | Director Elections | Board | AGAINST | 2 | |
| Brilliance China Automotive Holdings Limited | June 18, 2026 | Elect Song Jian as Director | Director Elections | Board | AGAINST | 2 | |
| Britannia Industries Limited | October 4, 2025 | Elect Rajesh Kumar Batra as Director | Director Elections | Board | AGAINST | 2 | |
| Budweiser Brewing Company APAC Limited | May 14, 2026 | Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 | |
| Buzzi SpA | May 13, 2026 | Approve Remuneration Policy | Compensation | Board | AGAINST | 2 | |
| By-health Co., Ltd. | August 25, 2025 | Approve Dividends Management System | Capital Structure | Board | AGAINST | 2 | |
| CALB Group Co., Ltd. | June 9, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 2 | |
| CALB Group Co., Ltd. | June 9, 2026 | Approve Rongcheng (Hong Kong) CPA Limited as Auditor for H Shares and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 | |
| CECEP Solar Energy Co., Ltd. | May 15, 2026 | Approve Additional Guarantee | Capital Structure | Board | AGAINST | 2 | |
| CECEP Solar Energy Co., Ltd. | May 15, 2026 | Approve to Appoint Financial and Internal Control Auditor | Audit-related | Board | AGAINST | 2 | |
| CG Power & Industrial Solutions Limited | July 24, 2025 | Reelect P S Jayakumar as Director | Director Elections | Board | AGAINST | 2 | |
| CGN Power Co., Ltd. | May 20, 2026 | Approve Grant of General Mandate to the Board of Directors for Allotting, Issuing and Dealing with Additional A Shares and/or H Shares | Capital Structure | Board | AGAINST | 2 | |
| CIMB Group Holdings Berhad | April 29, 2026 | Approve Allocation of New Shares to Muhammad Novan Amirudin under the Long Term Incentive Plan 2.0 | Compensation | Board | AGAINST | 2 | |
| CIMB Group Holdings Berhad | April 29, 2026 | Approve Establishment of Proposed Long-Term Incentive Plan (Proposed LTIP 2.0) | Compensation | Board | AGAINST | 2 | |
| CJ CheilJedang Corp. | March 24, 2026 | Approve Total Remuneration of Inside Directors and Outside Directors | Compensation | Board | AGAINST | 2 | |
| CK Infrastructure Holdings Limited | May 20, 2026 | Approve Deloitte Touche Tohmatsu as Auditor and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 | |
| CLP Holdings Limited | May 8, 2026 | Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 | |
| CMOC Group Limited | October 15, 2025 | Approve H Share Restricted Share Scheme | Compensation | Board | AGAINST | 2 | |
| CMOC Group Limited | October 15, 2025 | Approve Scheme Mandate Limit | Compensation | Board | AGAINST | 2 | |
| CMOC Group Limited | October 15, 2025 | Approve Service Provider Sublimit | Compensation | Board | AGAINST | 2 | |
| CMOC Group Limited | October 15, 2025 | Authorize Board and/or Its Delegatee(s) to Handle Matters in Relation to H Share Restricted Share Scheme | Compensation | Board | AGAINST | 2 | |
| CMOC Group Limited | April 28, 2026 | Approve Grant of General Mandate to the Board for Issuance of Additional A Shares and/or H Shares | Capital Structure | Board | AGAINST | 2 | |
| CMOC Group Limited | April 28, 2026 | Approve Purchase of Structured Deposit with Internal Idle Fund | Extraordinary Transactions | Board | AGAINST | 2 | |
| CMOC Group Limited | April 28, 2026 | Authorize Board to Decide on Issuance of Debt Financing Instruments | Capital Structure | Board | AGAINST | 2 | |
| CNGR Advanced Material Co., Ltd. | September 10, 2025 | Amend Remuneration Management Methods for Directors and Senior Management Members | Compensation | Board | AGAINST | 2 | |
| CNGR Advanced Material Co., Ltd. | October 15, 2025 | Approve Financial Assistance Provision | Capital Structure | Board | AGAINST | 2 | |
| CNGR Advanced Material Co., Ltd. | March 23, 2026 | Approve Proposed Application for Composite Credit Facilities and Guarantees and Its Subsidiaries from Banks and Other Institutions | Capital Structure | Board | AGAINST | 2 | |
| CNGR Advanced Material Co., Ltd. | May 22, 2026 | Approve General Mandate for the Issuance of Additional A Shares or H Shares | Capital Structure | Board | AGAINST | 2 | |
| COSCO SHIPPING Development Co., Ltd. | June 30, 2026 | Approve BDO Limited as International Auditor and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 | |
| COSCO SHIPPING Energy Transportation Co., Ltd. | June 26, 2026 | Approve Grant of the Issuance Mandate to the Board | Capital Structure | Board | AGAINST | 2 | |
| CRISPR Therapeutics AG | June 4, 2026 | Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. | Compensation | Board | AGAINST | 2 | |
| CRISPR Therapeutics AG | June 4, 2026 | Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. | Compensation | Board | AGAINST | 2 | |
| CRISPR Therapeutics AG | June 4, 2026 | Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. | Compensation | Board | AGAINST | 2 | |
| CRISPR Therapeutics AG | June 4, 2026 | Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027. | Compensation | Board | AGAINST | 2 | |
| CRISPR Therapeutics AG | June 4, 2026 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. | Compensation | Board | AGAINST | 2 | |
| CRISPR Therapeutics AG | June 4, 2026 | Non-binding advisory vote on the 2025 Compensation Report. | Compensation | Board | AGAINST | 2 | |
| CRISPR Therapeutics AG | June 4, 2026 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. | Say-on-Pay | Board | AGAINST | 2 | |
| CRISPR Therapeutics AG | June 4, 2026 | Re-election of Ali Behbahani, M.D. | Director Elections | Board | AGAINST | 2 | |
| CRISPR Therapeutics AG | June 4, 2026 | Re-election of the members of the Compensation Committee: Re-election of Ali Behbahani, M.D. | Director Elections | Board | AGAINST | 2 | |
| CRRC Corporation Limited | September 22, 2025 | Elect Ngai Ming Tak as Director | Director Elections | Board | AGAINST | 2 | |
| CRRC Corporation Limited | June 16, 2026 | Approve Arrangement of Guarantees | Capital Structure | Board | AGAINST | 2 | |
| CRRC Corporation Limited | June 16, 2026 | Approve Grant of General Mandate to the Board to Issue Additional A Shares and H Shares | Capital Structure | Board | AGAINST | 2 | |
| CRRC Corporation Limited | June 16, 2026 | Approve Issuance of Debt Financing Instruments | Capital Structure | Board | AGAINST | 2 | |
| CSL Limited | October 28, 2025 | Approve Conditional Board Spill Resolution | Compensation | Board | AGAINST | 2 | |
| CSPC Innovation Pharmaceutical Co., Ltd. | April 8, 2026 | Approve Use of Idle Raised Funds and Own Funds for Cash Management | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC Pharmaceutical Group Limited | May 28, 2026 | Adopt New Share Option Scheme | Compensation | Board | AGAINST | 2 | |
| CSPC Pharmaceutical Group Limited | May 28, 2026 | Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 2 | |
| Caihong Display Devices Co., Ltd. | May 12, 2026 | Approve External Guarantee | Capital Structure | Board | AGAINST | 2 | |
| Caitong Securities Co., Ltd. | July 2, 2025 | Approve Downward Adjustment of Conversion Price | Capital Structure | Board | AGAINST | 2 | |
| Caitong Securities Co., Ltd. | May 20, 2026 | Approve Securities Investment | Extraordinary Transactions | Board | AGAINST | 2 | |
| Caliway Biopharmaceuticals Co. Ltd. | May 22, 2026 | Amend 2025 Regulations of the Issuance of Restricted Stocks | Compensation | Board | AGAINST | 2 |
← Previous Page 18 of 55 Next →
← Back to Franklin Templeton 2025-2026 overview
Built October 18, 2026 from SEC Form N-PX filings.